Constitute committee to ensure pharma firms don't indulge in unethical practices: SC to Centre
First reported 8 Oct, 05:47 UTCUpdated 10h ago9 sources
2 left · 5 center · 2 right · Full breakdown
Polyview Briefing
AI-generatedThe Supreme Court directed the Centre to constitute a committee to address alleged unethical marketing practices by pharmaceutical companies, including offering doctors gifts and trips, following a petition seeking regulation.
How the Left framed it
Left‑leaning outlets stress the concern that pharma firms give doctors expensive gifts, overseas trips and other incentives to push particular drugs.
How the Center framed it
Center outlets note that the Court ordered a committee to consider suggestions and recommend a statutory framework to curb such marketing, citing a 2021 petition filed by the Federation of Medical and Sales Representatives Association.
How the Right framed it
Right‑leaning outlets frame the move as the Court examining and labeling the practice of pharma companies providing gifts, hospitality and cash to doctors as unethical, based on a public‑interest litigation.
What everyone reports
- The Supreme Court ordered the Centre to form a committee/panel.
- The committee is intended to address unethical marketing practices by pharmaceutical companies.
- Pharma companies have been accused of offering doctors gifts, trips, and other benefits.
- The order came in response to a petition seeking regulation of such practices.
Where coverage differs
- Identity of the petitioner: centre outlets say it was the Federation of Medical and Sales Representatives Association (2021 petition); right‑leaning outlets refer only to a public‑interest litigation.
- Purpose of the committee: centre outlets describe it as drafting a statutory framework and considering suggestions; left outlets simply note it will regulate unethical marketing.
- Emphasis on examination vs regulation: right‑leaning outlets highlight the Court’s examination of the practice as unethical, while left‑leaning outlets focus on the concerns about gifts and incentives.
Written by AI from the headlines and excerpts of 8 outlets (Ollama Cloud) on 8 Oct, 12:35 UTC. It can make mistakes — read the original reporting below. How briefings work
Compare the headlines
How outlets on each side framed it
New Delhi: The Supreme Court on Thursday directed the Centre to constitute a committee within two weeks to undertake a holistic and comprehensive examination of issues relating to unethical pharmaceutical marketing practices. '10-fold medicine markups are extortion, fraud & dacoity', says Supreme Court Supreme Court…
The Supreme Court on Thursday in its judgement has directed the Union of India (UOI) to constitute a committee to review the representations regarding unethical drug promotion practices and mandatory implementation of marketing code for pharmaceutical companies that give freebies to doctors. A two-judge Bench of the…
The Supreme Court will examine the practice of pharmaceutical companies offering doctors expensive gifts, foreign trips and other benefits to boost the sale of medicines. The court has directed the Centre to constitute a committee to look into the issue. The committee will examine the concerns raised over the…
Full coverage
9 outlets — tap a headline to read it at the source
- Constitute committee to ensure pharma firms don't indulge in unethical practices: SC to Centre (opens Hindustan Times in a new tab)
- SC asks Centre to constitute committee to ensure pharma firms don't indulge in unethical practices (opens The New Indian Express in a new tab)
The Supreme Court on Thursday in its judgement has directed the Union of India (UOI) to constitute a committee to review the representations regarding unethical drug promotion practices and mandatory implementation of marketing code for pharmaceutical companies that give freebies to doctors. A two-judge Bench of the…
- Constitute committee to ensure pharma firms don't indulge in unethical practices: SC to Centre (opens CNBC-TV18 in a new tab)
The Supreme Court directed the Centre to form a committee to recommend a statutory framework to curb unethical marketing practices by pharmaceutical companies.
- SC directs Centre to form panel on curbing unethical pharma marketing practices (opens India Today in a new tab)
- Supreme Court asks Centre to form panel to prevent pharma companies from indulging in unethical practices (opens Business Today in a new tab)
The order was passed while hearing a 2021 petition filed by the Federation of Medical and Sales Representatives Association, which sought regulation of unethical marketing practices by pharmaceutical companies.
- Supreme Court Orders Centre To Form Panel On Pharma Gifts, Foreign Trips For Doctors (opens ABP Live in a new tab)
The Supreme Court will examine the practice of pharmaceutical companies offering doctors expensive gifts, foreign trips and other benefits to boost the sale of medicines. The court has directed the Centre to constitute a committee to look into the issue. The committee will examine the concerns raised over the…
- Form Committee To End Unethical Marketing Practices By Pharma Companies: SC To Centre (opens Times Now in a new tab)
PIL complained that pharma companies offered gifts, tour/hospitality packages, and cash to doctors to prescribe medicines produced by them to patients, and termed it unethical.
- Set up panel to examine ‘unethical’ pharma marketing practices: Supreme Court to Govt (opens Deccan Herald in a new tab)
New Delhi: The Supreme Court on Thursday directed the Centre to constitute a committee within two weeks to undertake a holistic and comprehensive examination of issues relating to unethical pharmaceutical marketing practices. '10-fold medicine markups are extortion, fraud & dacoity', says Supreme Court Supreme Court…
- SC directs Centre to form expert panel to regulate unethical pharma marketing (opens The Hindu in a new tab)
The petition had raised concerns over pharmaceutical companies allegedly offering doctors expensive gifts, overseas trips, and other incentives to encourage the prescription of particular drugs
